Correlation Between Bio Gene and National Australia

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bio Gene and National Australia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Gene and National Australia into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Gene Technology and National Australia Bank, you can compare the effects of market volatilities on Bio Gene and National Australia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Gene with a short position of National Australia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Gene and National Australia.

Diversification Opportunities for Bio Gene and National Australia

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Bio and National is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Bio Gene Technology and National Australia Bank in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on National Australia Bank and Bio Gene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Gene Technology are associated (or correlated) with National Australia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of National Australia Bank has no effect on the direction of Bio Gene i.e., Bio Gene and National Australia go up and down completely randomly.

Pair Corralation between Bio Gene and National Australia

Assuming the 90 days trading horizon Bio Gene is expected to generate 36.38 times less return on investment than National Australia. In addition to that, Bio Gene is 17.6 times more volatile than National Australia Bank. It trades about 0.0 of its total potential returns per unit of risk. National Australia Bank is currently generating about 0.1 per unit of volatility. If you would invest  9,647  in National Australia Bank on September 14, 2024 and sell it today you would earn a total of  781.00  from holding National Australia Bank or generate 8.1% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.63%
ValuesDaily Returns

Bio Gene Technology  vs.  National Australia Bank

 Performance 
       Timeline  
Bio Gene Technology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Bio Gene Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Bio Gene is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
National Australia Bank 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in National Australia Bank are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, National Australia is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Bio Gene and National Australia Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bio Gene and National Australia

The main advantage of trading using opposite Bio Gene and National Australia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Gene position performs unexpectedly, National Australia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in National Australia will offset losses from the drop in National Australia's long position.
The idea behind Bio Gene Technology and National Australia Bank pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device